0001213900-20-019108.txt : 20200730 0001213900-20-019108.hdr.sgml : 20200730 20200729180113 ACCESSION NUMBER: 0001213900-20-019108 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200730 DATE AS OF CHANGE: 20200729 EFFECTIVENESS DATE: 20200730 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gain Therapeutics, Inc. CENTRAL INDEX KEY: 0001819411 IRS NUMBER: 851726310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-372084 FILM NUMBER: 201058256 BUSINESS ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: (301) 500-1556 MAIL ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 D 1 primary_doc.xml X0708 D LIVE 0001819411 Gain Therapeutics, Inc. 4800 HAMPDEN LANE SUITE 200 BETHESDA MD MARYLAND 20814 (301) 500-1556 DELAWARE None None Corporation true 2020 Eric I. Richman 4800 Hampden Lane Suite 200 Bethesda MD MARYLAND 20814 Executive Officer Director Khalid Islam 4800 Hampden Lane Suite 200 Bethesda MD MARYLAND 20814 Director Lorenzo Leoni 4800 Hampden Lane Suite 200 Bethesda MD MARYLAND 20814 Director Proceeds may be used to pay for overhead and expenses which may include salaries. Marianne Bjordal 4800 Hampden Lane Suite 200 Bethesda MD MARYLAND 20814 Director Jeffrey Riley 4800 Hampden Lane Suite 200 Bethesda MD MARYLAND 20814 Director Biotechnology Decline to Disclose 06b false 2020-07-20 false true false 50000 Tribal Capital Markets, LLC 38901 None None 2 BRIDGE AVENUE RED BANK NJ NEW JERSEY 07701 AL ALABAMA AZ ARIZONA CA CALIFORNIA FL FLORIDA IN INDIANA MD MARYLAND NJ NEW JERSEY NY NEW YORK OH OHIO TX TEXAS PR PUERTO RICO false 10000000 10000000 0 false 48 800000 0 0 true Proceeds may be used to pay for overhead and expenses which may include salaries. false Gain Therapeutics, Inc. /s/ Eric I. Richman Eric I. Richman Chief Executive Officer 2020-07-29